Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Factors of Anti-TNFalfa-induced Deep Remission in Crohn's Disease

NCT02580864 is registered in ClinicalTrials.gov with Société des Produits Nestlé (SPN) as lead sponsor.

NCT NCT02580864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02580864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Factors of Anti-TNFalfa-induced Deep Remission in Crohn's Disease
Lead sponsor
Société des Produits Nestlé (SPN)
Phase
Observational
Overall status
Completed
Start date
October 31, 2015
Completion date
January 31, 2019
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease